Status:

ACTIVE_NOT_RECRUITING

Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study

Lead Sponsor:

Fred Hutchinson Cancer Center

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Obesity-Related Malignant Neoplasm

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This phase III trial compares telephone delivered Acceptance and Commitment Therapy to standard behavioral therapy for improving weight loss in overweight or obese participants. Acceptance and Commitm...

Detailed Description

OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive ACT telephone coaching over the course of 12 months, calls 1-16 weekly, calls 17-23 biweekly, and calls 24-25 monthly....

Eligibility Criteria

Inclusion

  • Overweight or obese (body mass index \[BMI\] \>= 27) but not heavier than BMI of 45.5 (measured by weight \& height)
  • Wants to lose weight in the next 30 days
  • Interested in learning skills to lose weight
  • Willing to be randomly assigned to either condition
  • Resides in United States (US)
  • Has daily access to their own phone and email
  • Does not have a medical or psychiatric condition that would limit their ability to comply with the behavioral recommendations of the program or pose a risk to the participant during weight loss, including meeting criteria for binge eating disorder, and meeting criteria for severe depression (CESD \>= 25), or a diagnosis of serious heart disease, diabetes, uncontrolled hypertension, or cancer without written confirmation of approval from their physician office
  • Not pregnant, planning to become pregnant or breastfeeding in the next 12 months
  • In the past 3 months changed the dosage of prescription medications that can cause a significant change in weight or appetite
  • Have not lost more than 5% of their weight in the past 6 months
  • Willing and able to read in English
  • Not participating in or planning to participate in other weight loss programs
  • Has not participated in our other ACT intervention studies
  • Does not meet criteria for combined heavy plus binge drinking
  • Has access to a Bluetooth-enabled device and Wi-Fi and/or data plan
  • Is not planning to have or has not recently had (past 12 months) bariatric surgery
  • For outcome data retention, eligibility criteria included: Willing to complete follow-up surveys, and provide email, phone, and mailing address

Exclusion

  • The reverse of the inclusion criteria

Key Trial Info

Start Date :

March 5 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 9 2026

Estimated Enrollment :

418 Patients enrolled

Trial Details

Trial ID

NCT04447313

Start Date

March 5 2021

End Date

November 9 2026

Last Update

November 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States, 98109